Views & Analysis Urgent need for clarity as government suspends pharmacy cut ... But reprieve may last only until plans have been reviewed.
Partner Content Partner Content The new CDF - Navigating Cancer Drug Access in England On July 29th 2016, the new process in England for cancer drugs seeking license went live - changing both the shape and potential requirements of the submissions process.
Debates & Insight Sponsored Brexit - What now for pharma? Join us for a one-hour live webinar entitled Brexit - What now for pharma?
Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.
Debates & Insight Sponsored Available on demand: Cancer Treatment Access: Strategy, Appr... Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.
Partner Content Partner Content IMS Health and Reltio Form Alliance to Deploy Advanced Infor... Providing Customers the Best in Big Data Technologies, High-Performance Analytics and Healthcare Information Capabilities
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
